Yahoo Italia Ricerca nel Web

Entra

Risultati di ricerca

  1. www.linkedin.com › in › maurizio-voi-76042914Maurizio Voi - Molecular Templates | LinkedIn

    View Maurizio Voi’s profile on LinkedIn, a professional community of 1 billion members. I was previously Chief Medical Officer at Molecular Templates. Before I was Vice…

    • 500+
    • 1.4K
    • University of Medicine
    • Molecular Templates

  2. www.fiercepharma.com › pharma › curis-announces-appointment-ofCuris Announces Appointment of Maurizio Voi, M.D. as Chief...

    8 nov 2011 · Pharma. Curis Announces Appointment of Maurizio Voi, M.D. as Chief Medical and Chief Development Officer. Nov 8, 2011 7:20am. - Dr. Voi brings over 20 years of broad industry experience...

  3. Immagini

    • Molecular Templates Appoints Dr. Maurizio Voi Chief Medical Officer ...
    • Conosciamo i premiati della 27^ edizione del Premio Ragusani nel Mondo ...
    • Maurizio Voi – Voi Carcereri Associati
    • Lo studio – Voi Carcereri Associati

    Mostra tutto

  4. www.globenewswire.com › en › news-releaseMolecular Templates Announces the Appointment of Dr. -...

    28 set 2023 · Voi will begin his new role on October 2, 2023. Dr. Voi joins MTEM from Novartis, where he served as Vice President, Global Program Head, for the PD-1 antibody Tislelizumab since April 2021.

    • Molecular Templates, Inc.

  5. www.lopinioneragusa.it › maurizio-voi-ricercatore-clinicoMAURIZIO VOI, RICERCATORE CLINICO ESPERTO DI TEMATICHE DELLO...

    27 lug 2022 · Originario di Ragusa, il dottor Voi è esperto di tematiche di sviluppo di farmaci anti-tumorali e per il trattamento di tumori solidi, settori in cui vanta decine di pubblicazioni all’interno delle principali riviste scientifiche mondiali.

  6. www.linkedin.com › posts › maurizio-voi-76042914_aacr2024Maurizio Voi on LinkedIn: #aacr2024

    Chief Medical Officer at Molecular Templates. 1d Edited. Preliminary reports of anti-tumor activity of MT-6402, a novel engineered toxin body (ETB) targeting PDL-1 in patients with...

  7. www.citybiz.co › article › 472433Molecular Templates Appoints Dr. Maurizio Voi Chief Medical...

    28 set 2023 · Voi will begin his new role on October 2, 2023. Dr. Voi joins MTEM from Novartis, where he served as Vice President, Global Program Head, for the PD-1 antibody Tislelizumab since April 2021.

  8. finance.yahoo.com › news › molecular-templates-announcesMolecular Templates Announces the Appointment of Dr. Maurizio Voi...

    28 set 2023 · Dr. Voi will begin his new role on October 2, 2023. Dr. Voi joins MTEM from Novartis, where he served as Vice President, Global Program Head, for the PD-1 antibody Tislelizumab since April...